Cartalax
A synthetic peptide bioregulator studied for cartilage and connective-tissue signaling.
Overview
Cartalax is a synthetic short-chain peptide developed within the same Russian “peptide bioregulator” research tradition that produced Epitalon and Pinealon. Rather than targeting a hormonal axis, bioregulator peptides like Cartalax are studied for organ- or tissue-specific regulatory signaling — in this case, cartilage and connective tissue.
Mechanism of Action
Peptide bioregulator theory proposes that short peptides can interact with gene-regulatory regions to influence protein synthesis in a tissue-specific manner. For Cartalax, research within this framework has focused on cartilage and joint-tissue cell signaling, though the precise molecular mechanism is less extensively characterized in independently reproduced literature than that of better-known peptides in this library.
Cited Research
Peptide bioregulator theory
Cartalax is part of a broader family of tissue-specific short peptide bioregulators studied by this research group.
Cartilage/connective-tissue signaling
Studied for organ-specific regulatory effects on cartilage-associated cell populations.
This is a summary, not an exhaustive review. Search the primary literature yourself: Cartalax on PubMed →
Safety & Handling
Cartalax should be handled only by qualified personnel in a laboratory setting, stored and reconstituted per its Certificate of Analysis, and kept refrigerated once reconstituted. It is not evaluated or approved by the FDA for any human or veterinary use.
Frequently Asked Questions
What is a “peptide bioregulator”?
It’s a research category of very short peptides studied for organ- or tissue-specific regulatory effects, based on a research program developed in Russian gerontology institutes over several decades.
Is Cartalax legal to purchase?
It’s legal to sell and purchase as a research chemical for laboratory use in the U.S. It is not approved by the FDA as a drug or supplement for human consumption.
Is this page medical advice?
No. This page summarizes published literature for research and educational context only. It does not recommend a dose, protocol, or use in humans or animals outside a laboratory setting.
Have a specific question about Cartalax?
Ask Signal IQ Rx — our research assistant trained on the Signal Library.